BBPvsSBIOETF Comparison
Virtus LifeSci Biotech Products ETF (BBP) and ALPS Medical Breakthroughs ETF (SBIO) belong to the same industry segment: Tomorrow's Treatments. BBP's top 3 sector exposures are and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.5% for SBIO. BBP is up 9.25% year-to-date (YTD) with +$30M in YTD flows. SBIO performs worse with 3.34% YTD performance, and +$24M in YTD flows. Run a side-by-side ETF comparison of BBP and SBIO below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
BBP vs SBIO performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP SBIO | -1.38%-4.14% | +7.00%+5.20% | +9.25%+3.34% | +43.65%+68.87% | +60.05%+65.55% | +58.90%+9.66% |
| Flows | BBP SBIO | +$4M+$152K | +$26M+$15M | +$30M+$24M | +$42M+$22M | +$45M+$69K | +$38M-$48M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP SBIO | +28.75%+34.60% | +24.06%+29.49% | +24.00%+30.27% | +26.36%+33.65% |
| Max drawdown | BBP SBIO | -7.49%-12.63% | -9.59%-12.63% | -25.54%-42.12% | -37.87%-53.11% |
| Max drawdown duration | BBP SBIO | 37d54d | 48d54d | 292d331d | 760d1611d |
BBP | SBIO | |
Last sale 6/12/2026 at 1:30 PM | $87.17 | $52.76 |
| Previous close 06/11/2026 | $86.80 | $52.09 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBP | SBIO | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBP | SBIO | |
|---|---|---|
| Last price | $87.17 | $52.76 |
| 1D performance | +0.42% | +1.29% |
| AuM | $78.43 M | $154.56 M |
| E/R | 0.79% | 0.5% |
BBP | SBIO | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | ALPS |
| Benchmark | LifeSci Biotechnology Products Index | S-Network Medical Breakthroughs Index |
| N° of holdings | 55 | - |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | December 30, 2014 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
